Comparison of the Variability of Hepatic Load Quantification in Iron and Fat Estimated by MRI at 1.5 and 3 Tesla

NCT ID: NCT03200457

Last Updated: 2022-02-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

92 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-07-20

Study Completion Date

2020-08-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study proposes to compare the results of two examinations at 1.5 and 3 Tesla obtained on the same day on a series of 80 patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Quantification of hepatic iron by MRI is validated at 1.5 Tesla on a small number of subjects with some discrepancies between the two most used techniques (liver to muscle ratio or calculation of the decay rate of the T2 \* signal). Since the initial publications at 1.5 Tesla, new technical innovations have emerged which can allow better quantification. Recently, the investigators have applied these innovations to Rennes and have validated (SURFER study) the possibility of making a quantification of iron and fat on two 3 Tesla devices with good results in a single apnea acquisition. But it is not uncommon to have, in a structure, different magnetic field devices, and it is important to ensure that the results are transposable. It is also crucial for multicentre or cohort studies to ensure consistency. It is therefore proposed to compare the results of two examinations at 1.5 and 3 Tesla obtained on the same day on a series of 80 patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Iron Hepatic Overload Fat Hepatic Overload

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with hepatic iron overload or steatosis

Each patient (80) will have two MRI exams on the same day: one performed in common practice on a 1.5 Tesla device and the other on a 3 Tesla device.

Group Type EXPERIMENTAL

1,5 Tesla abdominal MRI

Intervention Type DEVICE

Measurement of the fat and iron

3 Tesla abdominal MRI

Intervention Type DEVICE

Measurement of the fat and iron

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

1,5 Tesla abdominal MRI

Measurement of the fat and iron

Intervention Type DEVICE

3 Tesla abdominal MRI

Measurement of the fat and iron

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult 18 years of age or older;
* Having an MRI indication of iron and fat quantification;
* Benefiting from social security;
* Having given a free, informed and written consent.

Exclusion Criteria

Related to MRI

* Implantable cardiac pacemaker or defibrillator;
* Non-MRI cardiac valve compatible;
* Clips, stents, coils, etc ... no MRI compatible;
* Cochlear implants;
* Neuronal or peripheral stimulator;
* Foreign bodies metallic intra orbital or encephalic, foreign body close to the eyes, wound by metallic lash (war, ball);
* Endoprostheses placed for less than 4 weeks and osteosynthesis materials placed less than 6 weeks old;
* Claustrophobia;
* Pumps, tattoos, permanent make-up, intrauterine device, patches;
* Metallic, magnetic, non-removable material and close to the analysis field.

Other criteria

* unstable hemodynamic status, acute respiratory failure, general precarious condition or a need for continuous monitoring incompatible with MRI constraints;
* Persons subject to major legal protection (safeguarding justice, guardianship, trusteeship), persons deprived of liberty.
* Known pregnancy, breastfeeding.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yves Gandon, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Rennes University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital St Vincent du Groupement des Hôpitaux de l'Institut Catholique de Lille

Lille, , France

Site Status

CHU de Rennes

Rennes, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2017-A01291-52

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Imaging Intravenous Iron
NCT05609318 RECRUITING
Visualizing Vascular Mechanisms of Lipedema
NCT05464927 ACTIVE_NOT_RECRUITING